WASHINGTON (WJZ)– EpiPen manufacturer Mylan’s CEO was on the hot seat Wednesday in Capitol Hill due to nationwide outcry over skyrocketing EpiPen prices.
Congress laid into Heather Bresch for jacking up prices on a vital medication.
“You raised the price, what did you think was going to happen?” said Jason Chaffetz, chairman of the U.S. House Committee on Oversight and Reform.
Bresch tried to explain why EpiPen prices have climbed more than 500 percent in just the last 9 years as top execs got huge raises.
“You have five executives in five years that earned nearly $300 million in compensation,” said Chaffetz.